Comparison of effect of auriculotherapy and mefenamic acid on the severity and systemic symptoms of primary dysmenorrhea: a randomized clinical trial

Table 4 Comparison of the difference in VAS scores between groups

Time	Auriculotherapy group (n = 41)	Mefenamic acid group (n = 42)	^aP value	95% CI (L/H)
	Mean ± SD^b	Mean ± SD
1st cycle–control cycle	−1.73 ± 1.17	−1.11 ± 1.58	0.047	−1.2/−0.008
2nd cycle–control cycle	−2.26 ± 1.25	−1.53 ± 1.63	0.027	−1.3/−0.08
2nd cycle–1st cycle	−0.52 ± 1.09	−0.42 ± 1.09	0.68	−0.57/0.37

ISSN: 1745-6215